Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PTC✓SelectedUSD · PTCGSK vs PTC performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs PTC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+100.4%
PTC return
+303.1%
Excess return
-202.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioPTCExcessAlpha
1D-1.3%+0.1%-1.4%-1.4%
7D-3.1%-0.1%-3.0%-3.1%
30D-0.9%+1.4%-2.3%-1.0%
3M-4.2%+33.7%-37.9%-7.7%
6M-1.6%+36.0%-37.5%-5.7%
YTD+2.6%+12.4%-9.8%+0.5%
1Y+6.2%+13.2%-6.9%+3.9%
3Y+55.0%+27.2%+27.7%+47.1%
5Y+42.8%+66.8%-23.9%+28.7%
All+100.4%+303.1%-202.7%+55.4%

Cumulative growth

Daily Returns

Daily percentage return beside PTC.

Daily Out/Under-Performance

Portfolio return minus PTC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded PTC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling